Cellebrite DI Ltd. (CLBT)
(Delayed Data from NSDQ)
$17.61 USD
-0.26 (-1.45%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $17.61 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CLBT 17.61 -0.26(-1.45%)
Will CLBT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CLBT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CLBT
Company News for Aug 15, 2025
Cellebrite DI Ltd. (CLBT) Tops Q2 Earnings and Revenue Estimates
CLBT: What are Zacks experts saying now?
Zacks Private Portfolio Services
StoneCo Ltd. (STNE) Beats Q2 Earnings and Revenue Estimates
Match Group (MTCH) Lags Q2 Earnings Estimates
Cellebrite DI Ltd. (CLBT) Tops Q1 Earnings Estimates
Other News for CLBT
CLBT forms Upper Bollinger Band Walk on September 19
CLBT rises 3.53% on September 19, leaving the technical picture intact
Stochastic Reached Overbought appears for CLBT after 0.0% move
Cellebrite DI (CLBT) Receives a Rating Update from a Top Analyst
NR7 appears for CLBT after 0.98% move